Publications - Reports

Cilcare is a French biotech SME that focuses on the early detection and treatment of hearing disorders.

The purpose of this report is to evaluate the current status of the industrial robotics market in Japan.

The EU is one of the largest global producers of medical devices, and the biggest exporter with a trade surplus of 11 billion EUR in 2023. Japan is an essential trade partner ranking 3rd within the main destination countries of EU exports.

This report explores the recent market and technology trends in Japan’s chemical industry, with a focus on PFAS, highlighting opportunities and recommendations for European companies doing business in Japan or planning to enter the Japanese market.

NovAlix is a drug discovery-focused CRO that was founded in Strasbourg in 2002. Novalix helps advance and accelerate the therapeutic potential of new drug candidates, working alongside clients to complement their internal R&D efforts.

In this series, we present a concise overview of key developments taking place in Japan in the last three to four months surrounding various technological sectors, including digital technology, robotics, green technologies, and aerospace.

This report is aiming to provide an overview and insights into the Wine market in Japan.

This report identifies specific opportunities for EU companies within Japan's semiconductor sector.

This report identifies specific opportunities for EU companies within Japan's Quantum Technologies Sector. Japan has considerable demand for solutions applicable to the automotive, finance, and healthcare industries. Emphasis on cybersecurity and secure communication infrastructure further opens market opportunities in quantum cryptography and secure communications.

The purpose of this report is to evaluate the current state of the B2B industrial drone market in Japan. It offers insights into market trends and developments, specifically targeting EU-based small- and mid-sized companies that manufacture industrial drones and related products.